Amidst the anticipated increase in vaccine-preventable diseases as the global population ages, a first-of-its-kind study has underscored the dual benefits of adult immunization programs. Beyond saving lives and preventing severe illnesses, the study found these programs offer substantial financial advantages to nations by reducing the need for costly hospitalizations and emergency medical interventions and avoiding […] Continue reading ->
“This is probably the most hopeful time in my professional life and the scariest time,” Dr Mike Ryan, the World Health Organization (WHO) Deputy Director General and head of Health Emergencies, told a high-level Geneva audience on Wednesday. “Hopeful” because there is the possibility of reaching a global agreement on how to tackle future pandemics […] Continue reading ->
Health stories are not just about medical facts; they are intricate tapestries woven with economic, political, and social threads, according to two international health journalists. Stephanie Nolen, a global health reporter for The New York Times, and Paul Adepoju, a Nigeria-based freelance health journalist and scientist who writes for Health Policy Watch, were guests on […] Continue reading ->
A new programme aiming at providing 1.2 million rapid cholera diagnostic tests has been launched in 14 African and Asian countries.  “Routine use of diagnostics will bolster cholera surveillance in impacted countries, and must be leveraged to better target vaccination efforts, which play a critical role in multisectoral cholera prevention and control programmes,” said Aurélia […] Continue reading ->
Speaking out on World Health Day, WHO Director General Dr Tedros Adhanom Ghebreyesus decried the destruction of Gaza’s Al-Shifa hospital and blamed Israel for the devastation, saying that the “atrocity” of the Hamas attacks on Israeli communities 7 October, did not justify “the horrific ongoing bombardment, seige and health system demolition by Israel in Gaza.” […] Continue reading ->
Demand for diabetes drugs such as Wegovy, Ozempic, Rybelsis and Trulicity has soared since they have been clinically proven to help weight loss – but they are massively overpriced in the US and unavailable in most low- and middle-income countries (LMIC), according to Médecins Sans Frontières (MSF). The mark-up for these drugs – called glucagon-like […] Continue reading ->